Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Mustang Bio, Inc. (MBIO) had Consolidated Net Income/Loss of $-15.75M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-15.75M |
|
-- |
|
-- |
|
$16.25M |
|
$-16.25M |
|
$0.49M |
|
$-15.75M |
|
$-15.75M |
|
$-15.75M |
|
$-15.75M |
|
|
Consolidated Net Income/Loss |
$-15.75M |
$-15.75M |
|
$-16.25M |
|
$-15.42M |
|
0.61M |
|
0.61M |
|
$-38.57 |
|
$-38.57 |
|
| Balance Sheet Financials | |
$8.61M |
|
$0.37M |
|
$0.70M |
|
$9.31M |
|
$12.61M |
|
-- |
|
$0.57M |
|
$13.18M |
|
$-3.87M |
|
$-3.87M |
|
$-3.87M |
|
1.90M |
|
| Cash Flow Statement Financials | |
$-11.41M |
|
$0.00M |
|
$11.27M |
|
$6.98M |
|
$6.84M |
|
$-0.14M |
|
$0.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
406.71% |
|
406.71% |
|
-169.23% |
|
406.71% |
|
$-2.04 |
|
$-18.70 |
|
$-18.70 |
|